[3]Braly PS,Klevecz RR. Flow cytometric evaluation of ovarian cancer[J]. Cancer,2003,71(4): 1621-1630.
[4]Fribhmder ML. Clinical and biological significance of anerploidy in human tumors[J]. J Clin Pathol,2001,39:961.
[5]Kaern J,Trope C,Kjorstad KE,et al. Cellular DNA content as a new prognostic tool in patients with borderline tumors of ovary[J]. Gynecol Oncol,2005,38(3):452.
上一页 [1] [2] [3]